CDKN2A and neoplasm: The immune rich phenotype is characterized by abundant T cell and B cell infiltration, with fewer FOXP3+ Tregs, lower tumor budding frequency, and low mutations in CDKN2A and PIK3CA. The CA19-9 levels are the lowest among the three groups, which correlates with the best prognosis.